Bristol-Myers Squibb Company (BMY) Shareholders’ equity 2016–2025
Bristol-Myers Squibb Company (BMY) shareholders’ equity at each fiscal year-end, per SEC filings.
$18.5BFY2025 · since FY2016: $16.2B → $18.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18.5B | +13.1% |
| FY2024 | $16.3B | -44.5% |
| FY2023 | $29.4B | -5.3% |
| FY2022 | $31.1B | -13.6% |
| FY2021 | $35.9B | -5.0% |
| FY2020 | $37.8B | -26.7% |
| FY2019 | $51.6B | +267.7% |
| FY2018 | $14.0B | +19.5% |
| FY2017 | $11.7B | -27.4% |
| FY2016 | $16.2B | — |
Source: SEC XBRL filings · For reference only · Not investment advice